When in May 2021 I emailed bioMérieux’s ex-CEO (2007–2011), Stéphane Bancel, to ask him if he knew that his company had violated its contract to provide a functional system, he did not reply. Bancel by that time was CEO of Moderna and a partner of Bill Gates and Tony Fauci, operating a company that would be the primary beneficiary of the lab leak, quickly making Bancel’s 9 percent stake worth over $1 billion and counting. In March 2019, eight months before COVID-19 began circulating, Bancel had reapplied for a patent for an mRNA technology for Moderna’s new vaccine. The US patent office had
...more
